Literature DB >> 23890670

Estimation of the incidence of Kawasaki disease in Taiwan. A comparison of two data sources: nationwide hospital survey and national health insurance claims.

Hung-Chi Lue1, Lei-Ru Chen2, Ming-Tai Lin2, Luan-Yin Chang2, Jou-Kou Wang2, Chin-Yun Lee2, Mei-Hwan Wu2.   

Abstract

BACKGROUND: Kawasaki disease (KD), first described by Dr. Tomisaku Kawasaki in 1967, was found for the first time in Taiwan in 1976. It continued to occur in increased numbers. For the study of incidence rates and epidemiological features of KD, we conducted five nationwide hospital surveys (NHS) in 1987, 1992, 1994, 2001 and 2008, respectively. We estimated also the annual incidence rates of KD during 1996-2007, based on the National Health Insurance (NHI) database, which had been implemented since 1995, covering 98% of the population in Taiwan.
METHODS: The annual incidence rates of KD during the twelve years, from1996 to 2007, estimated by the NHS and the NHI claims were compared, analyzed and discussed.
RESULTS: During 1996-2007, a total of 9,938 cases of KD were reported by the Departments of Pediatrics of all hospitals surveyed, and a total of 11,849 cases of KD were claimed in the NHI database. The annual number of cases and incidence rates of KD based on NHI claims constantly surpassed those by the NHS. The ratio of the two incidence rates varied from 1.10 to 1.33. They were well correlated (r = 0.902, p < 0.001) with a linear equation, NHI = 16.07 + 0.93*NHS. The changes in annual incidence rate by the NHI were mean 1.149, p = 0.07, 95% CI -0.082 - 2.382, and those by the NHS were mean 1.562, p <0.001, CI 0.656 - 2.468.
CONCLUSION: The annual incidence rates of KD can be estimated by the NHI claims and by the classic NHS. The values estimated by the NHI claims constantly outnumbered those by the NHS. Some pitfalls involved in the NHI claims are discussed.
Copyright © 2013. Published by Elsevier B.V.

Entities:  

Keywords:  Kawasaki disease; National Health Insurance claims; Taiwan; incidence of KD; nationwide questionnaire hospital survey

Mesh:

Year:  2013        PMID: 23890670     DOI: 10.1016/j.pedneo.2013.05.011

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  3 in total

1.  A Combination Therapy for Kawasaki Disease with Severe Complications: a Case Report.

Authors:  Yuriko Abe; Mamoru Ayusawa; Kengo Kawamura; Ryuta Yonezawa; Masataka Kato; Akiko Komori; Ryutaro Kohira; Ichiro Morioka
Journal:  Open Med (Wars)       Date:  2019-12-26

2.  Diagnosis of Kawasaki Disease Using a Minimal Whole-Blood Gene Expression Signature.

Authors:  Victoria J Wright; Jethro A Herberg; Myrsini Kaforou; Chisato Shimizu; Hariklia Eleftherohorinou; Hannah Shailes; Anouk M Barendregt; Stephanie Menikou; Stuart Gormley; Maurice Berk; Long Truong Hoang; Adriana H Tremoulet; John T Kanegaye; Lachlan J M Coin; Mary P Glodé; Martin Hibberd; Taco W Kuijpers; Clive J Hoggart; Jane C Burns; Michael Levin
Journal:  JAMA Pediatr       Date:  2018-10-01       Impact factor: 16.193

3.  Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia.

Authors:  Hun-Ju Yu; Meng-Ni Chuang; Chiao-Lun Chu; Pei-Lin Wu; Shu-Chen Ho; Ho-Chang Kuo
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.